Represented a biotechnology company focused on novel pharmaceutical therapies that seek to exploit RNA
editing and DNA
editing enzymes, in negotiating a license into the company relating to its core
technology, and
represent the company with regard to the creation and maintenance of its stock option plan and other general legal matters.
By posting or otherwise making available any User Content on or through the Service, you expressly grant, and you
represent and warrant that you have all rights necessary to grant, to Innocence Project a royalty - free, sublicensable, transferable, perpetual, irrevocable, non-exclusive, worldwide license to use, reproduce, modify, publish, list information regarding,
edit, translate, distribute, syndicate, publicly perform, publicly display, and make derivative works of all such User Content and your name, voice, and / or likeness as contained in your User Content, in whole or in part, and in any form, media or
technology, whether now known or hereafter developed, for use in connection with the Service and Innocence Project, including without limitation for promoting and redistributing part or all of the Service (and derivative works thereof) in any media formats and through any media channels and promoting the Service to other current and future Users.